Upgrade to SI Premium - Free Trial

Oracle (ORCL) PT Lowered to $245 at UBS

August 6, 2026 6:16 AM
UBS analyst Karl Keirstead lowered the price target on Oracle (NYSE: ORCL) to $245.00 (from $285.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change